The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4542783 5706628 F 4542783-6 20041214 20041214 20041231 EXP PHHO2004JP18297 NOVARTIS PHARMACEUTICALS CORP. 53 YR Y 52 KG 20041231 MD

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4542783 1005547025 PS *CGP 57148B* 2 ORAL
4542783 1005547026 C DIART 2
4542783 1005547027 C ALDACTONE-A 2
4542783 1005547028 C ASPARA K 2

Indications of drugs used

Event ID DRUG SEQ INDI PT
4542783 1005547025 GASTROINTESTINAL STROMAL TUMOUR

Outcome of event

Event ID OUTC COD
4542783 HO

Reactions reported

Event ID PT
4542783 INTERSTITIAL LUNG DISEASE
4542783 MALIGNANT NEOPLASM PROGRESSION

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4542783 HP

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4542783 1005547025 20021007